governance financial calendar contact order form publications a a a news 29 09 2016 medigene ag bluebird bio and medigene establish strategic t cell receptor tcr alliance in cancer more 26 09 2016 medigene participates at five national and international conferences more webcast webcast to press and analyst conference call regarding the publication of medigene s press release on 29 september 2016 1 2 three medigene develops three innovative immunotherapy platforms go phase ii part in dc study in leukaemia aml is ongoing 2 tcr strategic alliance with bluebird bio for t zell rezeptoren conference calendar 26 10 2016 heilbronn germany 6 . equity forum 2016 more events 10 11 2016 9 months report 2016 more tcrs audio visual medigene s tcrs audio visual dcs audio visual medigene s dcs audio visual tabs audio visual medigene s tabs audio visual bluebird bio is an ideal partner for us to jointly discover and develop a new generation of t cell therapeutics to treat unmet oncology indications we are delighted to collaborate with them . prof. dr dolores schendel ceo cso 6m 2016 6 months report 2016 downloads medigene corporate presentation 6 months report 2016 presentation analyst call 6 months report 2016 quarterly statement q1 2016 financial report 2015 ar 2015 annual report 2015 print imprint privacy sitemap glossary disclaimer links directions